Eugene Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Eugene Wang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Art S. Fergusson
1 shared publication- Breanna Teo
Swan Hill District Hospital, Swan Hill, Victoria, Australia
1 shared publication - Gary D. Fireman
Department of Psychology, Suffolk University
1 shared publication Jeremy Grummet
Department of Urology Alfred Health Melbourne VIC Australia
1 shared publication- Joshua Sungho Hong
Department of General Surgery, Swan Hill District Health, Victoria, Australia
1 shared publication Kirsten Herbert
Department of Clinical Haematology Peter MacCallum Cancer Centre and The Royal Melbourne Hospital Melbourne Victoria Australia
1 shared publication
Latest Publications
- Open Access
- 12 October 2026
- Published by Wiley in BJU International
Transurethral ultrasound ablation ( TULSA ) for prostate cancer: a systematic review and meta‐analysis
Objective: Our objective was to synthesise evidence on oncological, functional and safety outcomes of magnetic resonance imaging‐guided transurethral ultrasound ablation (TULSA) for primary and recurrent prostate cancer. Methods: MEDLINE, Embase, Web of Science and Scopus were systematically searched from inception to July 2025. The primary outcomes were 12‐month biopsy‐proven clinically significant prostate cancer (csPCa) recurrence‐free survival (RFS) and rates of pad‐free continence and preserved erectile function at last follow‐up. Secondary outcomes included biochemical recurrence, progression to salvage treatment and rates of adverse effects. Results: Twelve studies comprising 630 patients were analysed. In total, 563 (89%) patients underwent primary TULSA, 57 (9%) patients underwent salvage TULSA, and 10 (2%) patients had palliative TULSA. Pooled 12‐month csPCa RFS was 70% (95% confidence interval [CI] 50–84) for primary TULSA and 80% (95% CI 66–89) for salvage TULSA. Stratifying by ablation fraction, pooled 12‐month csPCa RFS was 75% (95% CI 60–86) for whole‐gland TULSA, and 71% (95% CI 51–86) for focal TULSA. The proportion of pad‐free continence was 90% (95% CI 71–97), and the rate of preservation of erectile function was 81% (95% CI 56–94). Incidence of grade 3 severity adverse events was 6% (95% CI 4–11). There was heterogeneity in multiple outcomes, likely reflecting variation in endpoint definitions, treatment approaches and follow‐up protocols among the included studies. Conclusion: Primary TULSA is a safe treatment modality with a low risk of functional morbidity. However, there is a lack of evidence on long‐term oncological control, with modifications of the treatment technique and ablation parameters still being experimental. Fewer data are available for salvage TULSA, where preliminary studies have recorded relatively high rates of incontinence.
- 12 October 2026
- Published by Wiley in BJU International
Open AccessTransurethral ultrasound ablation ( TULSA ) for prostate cancer: a systematic review and meta‐analysis
Objective: Our objective was to synthesise evidence on oncological, functional and safety outcomes of magnetic resonance imaging‐guided transurethral ultrasound ablation (TULSA) for primary and recurrent prostate cancer. Methods: MEDLINE, Embase, Web of Science and Scopus were systematically searched from inception to July 2025. The primary outcomes were 12‐month biopsy‐proven clinically significant prostate cancer (csPCa) recurrence‐free survival (RFS) and rates of pad‐free continence and preserved erectile function at last follow‐up. Secondary outcomes included biochemical recurrence, progression to salvage treatment and rates of adverse effects. Results: Twelve studies comprising 630 patients were analysed. In total, 563 (89%) patients underwent primary TULSA, 57 (9%) patients underwent salvage TULSA, and 10 (2%) patients had palliative TULSA. Pooled 12‐month csPCa RFS was 70% (95% confidence interval [CI] 50–84) for primary TULSA and 80% (95% CI 66–89) for salvage TULSA. Stratifying by ablation fraction, pooled 12‐month csPCa RFS was 75% (95% CI 60–86) for whole‐gland TULSA, and 71% (95% CI 51–86) for focal TULSA. The proportion of pad‐free continence was 90% (95% CI 71–97), and the rate of preservation of erectile function was 81% (95% CI 56–94). Incidence of grade 3 severity adverse events was 6% (95% CI 4–11). There was heterogeneity in multiple outcomes, likely reflecting variation in endpoint definitions, treatment approaches and follow‐up protocols among the included studies. Conclusion: Primary TULSA is a safe treatment modality with a low risk of functional morbidity. However, there is a lack of evidence on long‐term oncological control, with modifications of the treatment technique and ablation parameters still being experimental. Fewer data are available for salvage TULSA, where preliminary studies have recorded relatively high rates of incontinence.
- 11 August 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (8) , e267234
Importance of preoperative gastroscopy prior to bariatric surgery: a perspective from a regional centre
We report a case of an Australian man in his early 50s, with a BMI of 42.2 kg/m2, who was being worked up for elective bariatric surgery. Initial gastroscopy was unremarkable; however, repeat preoperative gastroscopy 20 months later identified Barrett’s oesophagus. Subsequent histology confirmed oesophageal adenocarcinoma. This report highlights the importance of preoperative workup of patients undergoing bariatric surgery. We advocate for preoperative gastroscopies as a part of the immediate workup prior to any bariatric procedure.
- 11 August 2025
- Published by BMJ in BMJ Case Reports
- Vol. 18 (8) , e267234
Importance of preoperative gastroscopy prior to bariatric surgery: a perspective from a regional centre
We report a case of an Australian man in his early 50s, with a BMI of 42.2 kg/m2, who was being worked up for elective bariatric surgery. Initial gastroscopy was unremarkable; however, repeat preoperative gastroscopy 20 months later identified Barrett’s oesophagus. Subsequent histology confirmed oesophageal adenocarcinoma. This report highlights the importance of preoperative workup of patients undergoing bariatric surgery. We advocate for preoperative gastroscopies as a part of the immediate workup prior to any bariatric procedure.
- 12 July 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 49 (12) , 1504-1509
Quality of life in patients with acquired dermal macular hyperpigmentation: a systematic review
Acquired dermal macular hyperpigmentation (ADMH) encompasses conditions including lichen planus pigmentosus, erythema dyschromicum perstans, ashy dermatosis, Riehl melanosis and pigmented contact dermatitis. This group of cosmetically distressing pigmentary disorders poses a therapeutic challenge, yet to our knowledge, there have been no systematic reviews published that describe their impact on quality of life (QoL). An electronic database search of PubMed, Embase, PsycINFO and Cochrane Library was performed in December 2022 to search for articles published from inception until 15 December 2022. Articles were included if they (i) were a primary clinical publication, (ii) reported QoL in patients with ADMH, and (iii) were available in full text. Overall, the review highlighted a considerable gap in the literature concerning the impact of ADMH on QoL. Seven studies fulfilling the inclusion criteria were included, with a total of 259 patients. All seven studies reported impaired QoL in patients with ADMH. The currently available literature on this topic indicates that ADMH has a significant adverse impact on QoL, likely to a greater degree than melasma, and to a similar or lesser degree than vitiligo. Five of seven studies reported the QoL impairment for patients with ADMH based on the Dermatology Life Quality Index (DLQI); these studies consistently found a mean DLQI score reflective of a moderate effect on patients’ QoL. Clinicians must be aware of the significant psychosocial burden associated with ADMH. This impact is often overlooked but should be considered when taking a holistic approach to management.
- 12 July 2024
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 49 (12) , 1504-1509
Quality of life in patients with acquired dermal macular hyperpigmentation: a systematic review
Acquired dermal macular hyperpigmentation (ADMH) encompasses conditions including lichen planus pigmentosus, erythema dyschromicum perstans, ashy dermatosis, Riehl melanosis and pigmented contact dermatitis. This group of cosmetically distressing pigmentary disorders poses a therapeutic challenge, yet to our knowledge, there have been no systematic reviews published that describe their impact on quality of life (QoL). An electronic database search of PubMed, Embase, PsycINFO and Cochrane Library was performed in December 2022 to search for articles published from inception until 15 December 2022. Articles were included if they (i) were a primary clinical publication, (ii) reported QoL in patients with ADMH, and (iii) were available in full text. Overall, the review highlighted a considerable gap in the literature concerning the impact of ADMH on QoL. Seven studies fulfilling the inclusion criteria were included, with a total of 259 patients. All seven studies reported impaired QoL in patients with ADMH. The currently available literature on this topic indicates that ADMH has a significant adverse impact on QoL, likely to a greater degree than melasma, and to a similar or lesser degree than vitiligo. Five of seven studies reported the QoL impairment for patients with ADMH based on the Dermatology Life Quality Index (DLQI); these studies consistently found a mean DLQI score reflective of a moderate effect on patients’ QoL. Clinicians must be aware of the significant psychosocial burden associated with ADMH. This impact is often overlooked but should be considered when taking a holistic approach to management.
- 7 March 2023
- Published by Wiley in Medical Journal of Australia
- Vol. 218 (6) , 250-251
Abdominal pain secondary to bilateral adrenal haemorrhage as the first presentation of antiphospholipid syndrome
- 7 March 2023
- Published by Wiley in Medical Journal of Australia
- Vol. 218 (6) , 250-251
Abdominal pain secondary to bilateral adrenal haemorrhage as the first presentation of antiphospholipid syndrome
- Top Cited PapersOpen Access
- 1 January 2023
- Published by SAGE Publications in Digital Health
- Vol. 9
A review of multi-factor authentication in the Internet of Healthcare Things
Objective: This review paper aims to evaluate existing solutions in healthcare authentication and provides an insight into the technologies incorporated in Internet of Healthcare Things (IoHT) and multi-factor authentication (MFA) applications for next-generation authentication practices. Our review has two objectives: (a) Review MFA based on the challenges, impact and solutions discussed in the literature; and (b) define the security requirements of the IoHT as an approach to adapting MFA solutions in a healthcare context. Methods: To review the existing literature, we indexed articles from the IEEE Xplore, ACM Digital Library, ScienceDirect, and SpringerLink databases. The search was refined to combinations of ‘authentication’, ‘multi-factor authentication’, ‘Internet of Things authentication’, and ‘medical authentication’ to ensure that the retrieved journal articles and conference papers were relevant to healthcare and Internet of Things-oriented authentication research. Results: The concepts of MFA can be applied to healthcare where security can often be overlooked. The security requirements identified result in stronger methodologies of authentication such as hardware solutions in combination with biometric data to enhance MFA approaches. We identify the key vulnerabilities of weaker approaches to security such as password use against various cyber threats. Cyber threats and MFA solutions are categorised in this paper to facilitate readers’ understanding of them in healthcare domains. Conclusions: We contribute to an understanding of up-to-date MFA approaches and how they can be improved for use in the IoHT. This is achieved by discussing the challenges, benefits, and limitations of current methodologies and recommendations to improve access to eHealth resources through additional layers of security.
- 1 January 2023
- Published by SAGE Publications in Digital Health
- Vol. 9
Top Cited PapersOpen AccessA review of multi-factor authentication in the Internet of Healthcare Things
Objective: This review paper aims to evaluate existing solutions in healthcare authentication and provides an insight into the technologies incorporated in Internet of Healthcare Things (IoHT) and multi-factor authentication (MFA) applications for next-generation authentication practices. Our review has two objectives: (a) Review MFA based on the challenges, impact and solutions discussed in the literature; and (b) define the security requirements of the IoHT as an approach to adapting MFA solutions in a healthcare context. Methods: To review the existing literature, we indexed articles from the IEEE Xplore, ACM Digital Library, ScienceDirect, and SpringerLink databases. The search was refined to combinations of ‘authentication’, ‘multi-factor authentication’, ‘Internet of Things authentication’, and ‘medical authentication’ to ensure that the retrieved journal articles and conference papers were relevant to healthcare and Internet of Things-oriented authentication research. Results: The concepts of MFA can be applied to healthcare where security can often be overlooked. The security requirements identified result in stronger methodologies of authentication such as hardware solutions in combination with biometric data to enhance MFA approaches. We identify the key vulnerabilities of weaker approaches to security such as password use against various cyber threats. Cyber threats and MFA solutions are categorised in this paper to facilitate readers’ understanding of them in healthcare domains. Conclusions: We contribute to an understanding of up-to-date MFA approaches and how they can be improved for use in the IoHT. This is achieved by discussing the challenges, benefits, and limitations of current methodologies and recommendations to improve access to eHealth resources through additional layers of security.
- Open Access
- 20 June 2022
- Published by Wiley in Dermatological Reviews
- Vol. 3 (5) , 326-335
An update and review of narrowband ultraviolet B phototherapy for vitiligo
Vitiligo is a chronic skin condition that results in depigmentation. It affects up to 2% of the population worldwide. Phototherapy is one of the most commonly used treatment methods for vitiligo. In the last few decades, there has been an increasing popularity of narrowband ultraviolet B phototherapy (NB‐UVB) over other forms of phototherapy to treat vitiligo. This paper reviews efficacy and safety of NB‐UVB treatment in vitiligo, including combination therapy with topical calcineurin inhibitors, corticosteroids, vitamin D analogs, antioxidants, and fractional CO2 laser. Advantages and limitations of home‐based phototherapy as an emerging alternative to conventional hospital‐based phototherapy will also be explored.
- 20 June 2022
- Published by Wiley in Dermatological Reviews
- Vol. 3 (5) , 326-335
Open AccessAn update and review of narrowband ultraviolet B phototherapy for vitiligo
Vitiligo is a chronic skin condition that results in depigmentation. It affects up to 2% of the population worldwide. Phototherapy is one of the most commonly used treatment methods for vitiligo. In the last few decades, there has been an increasing popularity of narrowband ultraviolet B phototherapy (NB‐UVB) over other forms of phototherapy to treat vitiligo. This paper reviews efficacy and safety of NB‐UVB treatment in vitiligo, including combination therapy with topical calcineurin inhibitors, corticosteroids, vitamin D analogs, antioxidants, and fractional CO2 laser. Advantages and limitations of home‐based phototherapy as an emerging alternative to conventional hospital‐based phototherapy will also be explored.
- 17 June 2022
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (1-2) , 410-411
Small bowel intussusception: an unusual presentation of metastatic leiomyosarcoma
- 17 June 2022
- Published by Wiley in Anz Journal of Surgery
- Vol. 93 (1-2) , 410-411
Small bowel intussusception: an unusual presentation of metastatic leiomyosarcoma
- 31 December 2018
- Published by Columbia University Press
- p. 265-309
VIII. Art and Vision. Varieties of World Making
- 31 December 2018
- Published by Columbia University Press
- p. 265-309
VIII. Art and Vision. Varieties of World Making